Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Surface Exposure of PEG and Amines on Biodegradable Nanoparticles as a Strategy to Tune Their Interaction with Protein-Rich Biological Media.

Conte C, Dal Poggetto G, J Swartzwelter B, Esposito D, Ungaro F, Laurienzo P, Boraschi D, Quaglia F.

Nanomaterials (Basel). 2019 Sep 20;9(10). pii: E1354. doi: 10.3390/nano9101354.

2.

Assessing Immunological Memory in the Solitary Ascidian Ciona robusta.

Melillo D, Marino R, Della Camera G, Italiani P, Boraschi D.

Front Immunol. 2019 Aug 16;10:1977. doi: 10.3389/fimmu.2019.01977. eCollection 2019.

3.

One hits (almost) all.

Boraschi D, Apte RN, Martin MU.

Nat Immunol. 2019 Sep;20(9):1095-1097. doi: 10.1038/s41590-019-0463-5. No abstract available.

PMID:
31427774
4.

Bovine colon organoids: From 3D bioprinting to cryopreserved multi-well screening platforms.

Töpfer E, Pasotti A, Telopoulou A, Italiani P, Boraschi D, Ewart MA, Wilde C.

Toxicol In Vitro. 2019 Jul 22;61:104606. doi: 10.1016/j.tiv.2019.104606. [Epub ahead of print]

PMID:
31344400
5.

In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment.

Rodriguez D, Goulart C, Pagliarone AC, Silva EP, Cunegundes PS, Nascimento IP, Borra RC, Dias WO, Tagliabue A, Boraschi D, Leite LCC.

Front Immunol. 2019 Jun 26;10:1460. doi: 10.3389/fimmu.2019.01460. eCollection 2019.

6.

Cytokines and soluble receptors of the interleukin-1 family in Schnitzler syndrome.

Migliorini P, Italiani P, Pratesi F, Puxeddu I, Boraschi D.

Scand J Rheumatol. 2019 May;48(3):235-238. doi: 10.1080/03009742.2018.1550210. Epub 2019 Jan 22.

PMID:
30668200
7.

Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression?

Italiani P, Puxeddu I, Napoletano S, Scala E, Melillo D, Manocchio S, Angiolillo A, Migliorini P, Boraschi D, Vitale E, Di Costanzo A.

J Neuroinflammation. 2018 Dec 12;15(1):342. doi: 10.1186/s12974-018-1376-1.

8.

Innate Immune Memory in Invertebrate Metazoans: A Critical Appraisal.

Melillo D, Marino R, Italiani P, Boraschi D.

Front Immunol. 2018 Aug 22;9:1915. doi: 10.3389/fimmu.2018.01915. eCollection 2018. Review.

9.

Innate Immune Memory: Time for Adopting a Correct Terminology.

Boraschi D, Italiani P.

Front Immunol. 2018 Apr 19;9:799. doi: 10.3389/fimmu.2018.00799. eCollection 2018. No abstract available.

10.

IL-1 family cytokines and soluble receptors in systemic lupus erythematosus.

Italiani P, Manca ML, Angelotti F, Melillo D, Pratesi F, Puxeddu I, Boraschi D, Migliorini P.

Arthritis Res Ther. 2018 Feb 8;20(1):27. doi: 10.1186/s13075-018-1525-z.

11.

Personalized risk prediction of postoperative cognitive impairment - rationale for the EU-funded BioCog project.

Winterer G, Androsova G, Bender O, Boraschi D, Borchers F, Dschietzig TB, Feinkohl I, Fletcher P, Gallinat J, Hadzidiakos D, Haynes JD, Heppner F, Hetzer S, Hendrikse J, Ittermann B, Kant IMJ, Kraft A, Krannich A, Krause R, Kühn S, Lachmann G, van Montfort SJT, Müller A, Nürnberg P, Ofosu K, Pietsch M, Pischon T, Preller J, Renzulli E, Scheurer K, Schneider R, Slooter AJC, Spies C, Stamatakis E, Volk HD, Weber S, Wolf A, Yürek F, Zacharias N; BioCog consortium.

Eur Psychiatry. 2018 Apr;50:34-39. doi: 10.1016/j.eurpsy.2017.10.004. Epub 2018 Feb 3.

PMID:
29398565
12.

The family of the interleukin-1 receptors.

Boraschi D, Italiani P, Weil S, Martin MU.

Immunol Rev. 2018 Jan;281(1):197-232. doi: 10.1111/imr.12606. Review.

PMID:
29248002
13.

Editorial: Interaction of Nanomaterials with the Immune System: Role in Nanosafety and Nanomedicine.

Boraschi D, Castellano LRC, Italiani P.

Front Immunol. 2017 Nov 28;8:1688. doi: 10.3389/fimmu.2017.01688. eCollection 2017. No abstract available.

14.

Bacterial endotoxin (lipopolysaccharide) binds to the surface of gold nanoparticles, interferes with biocorona formation and induces human monocyte inflammatory activation.

Li Y, Shi Z, Radauer-Preiml I, Andosch A, Casals E, Luetz-Meindl U, Cobaleda M, Lin Z, Jaberi-Douraki M, Italiani P, Horejs-Hoeck J, Himly M, Monteiro-Riviere NA, Duschl A, Puntes VF, Boraschi D.

Nanotoxicology. 2017 Nov - Dec;11(9-10):1157-1175. doi: 10.1080/17435390.2017.1401142. Epub 2017 Dec 1.

PMID:
29192556
15.

Nanoparticles and innate immunity: new perspectives on host defence.

Boraschi D, Italiani P, Palomba R, Decuzzi P, Duschl A, Fadeel B, Moghimi SM.

Semin Immunol. 2017 Dec;34:33-51. doi: 10.1016/j.smim.2017.08.013. Epub 2017 Aug 30. Review.

PMID:
28869063
16.

IL-1 family cytokines and receptors in IgG4-related disease.

Capecchi R, Italiani P, Puxeddu I, Pratesi F, Tavoni A, Boraschi D, Migliorini P.

Cytokine. 2018 Feb;102:145-148. doi: 10.1016/j.cyto.2017.08.001. Epub 2017 Aug 18.

PMID:
28823915
17.

Induction of Innate Immune Memory by Engineered Nanoparticles: A Hypothesis That May Become True.

Italiani P, Boraschi D.

Front Immunol. 2017 Jun 26;8:734. doi: 10.3389/fimmu.2017.00734. eCollection 2017.

18.

Different Regulation of Interleukin-1 Production and Activity in Monocytes and Macrophages: Innate Memory as an Endogenous Mechanism of IL-1 Inhibition.

Madej MP, Töpfer E, Boraschi D, Italiani P.

Front Pharmacol. 2017 Jun 8;8:335. doi: 10.3389/fphar.2017.00335. eCollection 2017.

19.

Poverty-Related Diseases College: a virtual African-European network to build research capacity.

Dorlo TPC, Fernández C, Troye-Blomberg M, de Vries PJ, Boraschi D, Mbacham WF.

BMJ Glob Health. 2016 Jun 10;1(1):e000032. doi: 10.1136/bmjgh-2016-000032. eCollection 2016.

20.

Endotoxin Contamination in Nanomaterials Leads to the Misinterpretation of Immunosafety Results.

Li Y, Fujita M, Boraschi D.

Front Immunol. 2017 May 8;8:472. doi: 10.3389/fimmu.2017.00472. eCollection 2017.

21.

Oxidative Stress and Inflammation Induced by Environmental and Psychological Stressors: A Biomarker Perspective.

Ghezzi P, Floridi L, Boraschi D, Cuadrado A, Manda G, Levic S, D'Acquisto F, Hamilton A, Athersuch TJ, Selley L.

Antioxid Redox Signal. 2018 Mar 20;28(9):852-872. doi: 10.1089/ars.2017.7147. Epub 2017 Jun 15. Review.

22.

Development and Functional Differentiation of Tissue-Resident Versus Monocyte-Derived Macrophages in Inflammatory Reactions.

Italiani P, Boraschi D.

Results Probl Cell Differ. 2017;62:23-43. doi: 10.1007/978-3-319-54090-0_2. Review.

PMID:
28455704
23.

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.

Anchordoquy TJ, Barenholz Y, Boraschi D, Chorny M, Decuzzi P, Dobrovolskaia MA, Farhangrazi ZS, Farrell D, Gabizon A, Ghandehari H, Godin B, La-Beck NM, Ljubimova J, Moghimi SM, Pagliaro L, Park JH, Peer D, Ruoslahti E, Serkova NJ, Simberg D.

ACS Nano. 2017 Jan 24;11(1):12-18. doi: 10.1021/acsnano.6b08244. Epub 2017 Jan 9.

24.

Assessing the Immunosafety of Engineered Nanoparticles with a Novel in Vitro Model Based on Human Primary Monocytes.

Li Y, Italiani P, Casals E, Valkenborg D, Mertens I, Baggerman G, Nelissen I, Puntes VF, Boraschi D.

ACS Appl Mater Interfaces. 2016 Oct 26;8(42):28437-28447. doi: 10.1021/acsami.6b06278. Epub 2016 Oct 13.

PMID:
27670583
25.

Endotoxin contamination: a key element in the interpretation of nanosafety studies.

Li Y, Boraschi D.

Nanomedicine (Lond). 2016 Feb;11(3):269-87. doi: 10.2217/nnm.15.196. Epub 2016 Jan 20. Review. Erratum in: Nanomedicine (Lond). 2016 Mar;11(6):739.

26.

From Antigen Delivery System to Adjuvanticy: The Board Application of Nanoparticles in Vaccinology.

Boraschi D, Italiani P.

Vaccines (Basel). 2015 Nov 5;3(4):930-9. doi: 10.3390/vaccines3040930. Review.

27.

Vaccines of the Future: The Role of Inflammation and Adjuvanticity.

Yun CH, Leite LC, Tagliabue A, Boraschi D.

J Immunol Res. 2015;2015:789595. doi: 10.1155/2015/789595. Epub 2015 Aug 26. No abstract available.

28.

Innate Immune Memory: The Latest Frontier of Adjuvanticity.

Töpfer E, Boraschi D, Italiani P.

J Immunol Res. 2015;2015:478408. doi: 10.1155/2015/478408. Epub 2015 Aug 25. Review.

29.

New Insights Into Tissue Macrophages: From Their Origin to the Development of Memory.

Italiani P, Boraschi D.

Immune Netw. 2015 Aug;15(4):167-76. doi: 10.4110/in.2015.15.4.167. Epub 2015 Aug 26. Review.

30.

From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation.

Italiani P, Boraschi D.

Front Immunol. 2014 Oct 17;5:514. doi: 10.3389/fimmu.2014.00514. eCollection 2014. Review.

31.

Optimising the use of commercial LAL assays for the analysis of endotoxin contamination in metal colloids and metal oxide nanoparticles.

Li Y, Italiani P, Casals E, Tran N, Puntes VF, Boraschi D.

Nanotoxicology. 2015 May;9(4):462-73. doi: 10.3109/17435390.2014.948090. Epub 2014 Aug 14.

PMID:
25119419
32.

Induction of long-term immunity against respiratory syncytial virus glycoprotein by an osmotic polymeric nanocarrier.

Firdous J, Islam MA, Park SM, Cheon IS, Shim BS, Yoon HS, Song M, Chang J, Choi YJ, Park YM, Boraschi D, Han SH, Cho CS, Yun CH.

Acta Biomater. 2014 Nov;10(11):4606-4617. doi: 10.1016/j.actbio.2014.07.034. Epub 2014 Aug 8.

PMID:
25110285
33.

Challenges in the design of clinically useful brain-targeted drug nanocarriers.

Costantino L, Boraschi D, Eaton M.

Curr Med Chem. 2014;21(37):4227-46. Review.

PMID:
25039774
34.

Immunosenescence and vaccine failure in the elderly: strategies for improving response.

Boraschi D, Italiani P.

Immunol Lett. 2014 Nov;162(1 Pt B):346-53. doi: 10.1016/j.imlet.2014.06.006. Epub 2014 Jun 21. Review.

PMID:
24960535
35.

Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis.

Italiani P, Carlesi C, Giungato P, Puxeddu I, Borroni B, Bossù P, Migliorini P, Siciliano G, Boraschi D.

J Neuroinflammation. 2014 May 23;11:94. doi: 10.1186/1742-2094-11-94.

36.

Engineered nanoparticles. How brain friendly is this new guest?

Cupaioli FA, Zucca FA, Boraschi D, Zecca L.

Prog Neurobiol. 2014 Aug-Sep;119-120:20-38. doi: 10.1016/j.pneurobio.2014.05.002. Epub 2014 May 10. Review.

PMID:
24820405
37.

Transcriptomic profiling of the development of the inflammatory response in human monocytes in vitro.

Italiani P, Mazza EM, Lucchesi D, Cifola I, Gemelli C, Grande A, Battaglia C, Bicciato S, Boraschi D.

PLoS One. 2014 Feb 3;9(2):e87680. doi: 10.1371/journal.pone.0087680. eCollection 2014.

38.

MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation.

Gemelli C, Zanocco Marani T, Bicciato S, Mazza EM, Boraschi D, Salsi V, Zappavigna V, Parenti S, Selmi T, Tagliafico E, Ferrari S, Grande A.

Biochim Biophys Acta. 2014 May;1843(5):955-64. doi: 10.1016/j.bbamcr.2014.01.021. Epub 2014 Jan 25.

39.

Perspectives in immunopharmacology: the future of immunosuppression.

Boraschi D, Penton-Rol G.

Immunol Lett. 2014 Oct;161(2):211-5. doi: 10.1016/j.imlet.2013.11.017. Epub 2013 Dec 12. Review.

PMID:
24333342
40.

The interleukin-1 receptor family.

Boraschi D, Tagliabue A.

Semin Immunol. 2013 Dec 15;25(6):394-407. doi: 10.1016/j.smim.2013.10.023. Epub 2013 Nov 15. Review.

PMID:
24246227
41.

Immunomodulatory activity of a novel, synthetic beta-glucan (β-glu6) in murine macrophages and human peripheral blood mononuclear cells.

Li X, Wang J, Wang W, Liu C, Sun S, Gu J, Wang X, Boraschi D, Huang Y, Qu D.

PLoS One. 2013 Nov 6;8(11):e80399. doi: 10.1371/journal.pone.0080399. eCollection 2013.

42.

The gracefully aging immune system.

Boraschi D, Aguado MT, Dutel C, Goronzy J, Louis J, Grubeck-Loebenstein B, Rappuoli R, Del Giudice G.

Sci Transl Med. 2013 May 15;5(185):185ps8. doi: 10.1126/scitranslmed.3005624. Review.

PMID:
23677590
43.

Concern-driven integrated approaches to nanomaterial testing and assessment--report of the NanoSafety Cluster Working Group 10.

Oomen AG, Bos PM, Fernandes TF, Hund-Rinke K, Boraschi D, Byrne HJ, Aschberger K, Gottardo S, von der Kammer F, Kühnel D, Hristozov D, Marcomini A, Migliore L, Scott-Fordsmand J, Wick P, Landsiedel R.

Nanotoxicology. 2014 May;8(3):334-48. doi: 10.3109/17435390.2013.802387. Epub 2013 May 28.

44.

Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria.

Puxeddu I, Italiani P, Giungato P, Pratesi F, Panza F, Bartaloni D, Rocchi V, Del Corso I, Boraschi D, Migliorini P.

Cytokine. 2013 Mar;61(3):741-3. doi: 10.1016/j.cyto.2013.01.015. Epub 2013 Feb 19.

PMID:
23433789
45.

Interaction of nanoparticles with immunocompetent cells: nanosafety considerations.

Boraschi D, Costantino L, Italiani P.

Nanomedicine (Lond). 2012 Jan;7(1):121-31. doi: 10.2217/nnm.11.169. Review.

PMID:
22191781
46.

Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?

Costantino L, Boraschi D.

Drug Discov Today. 2012 Apr;17(7-8):367-78. doi: 10.1016/j.drudis.2011.10.028. Epub 2011 Nov 7. Review.

PMID:
22094246
47.

IL-37: a new anti-inflammatory cytokine of the IL-1 family.

Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, Oostingh GJ, Pfaller T, Pixner C, Posselt G, Italiani P, Nold MF, Nold-Petry CA, Bufler P, Dinarello CA.

Eur Cytokine Netw. 2011 Sep;22(3):127-47. doi: 10.1684/ecn.2011.0288. Review.

48.

Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects.

Oostingh GJ, Casals E, Italiani P, Colognato R, Stritzinger R, Ponti J, Pfaller T, Kohl Y, Ooms D, Favilli F, Leppens H, Lucchesi D, Rossi F, Nelissen I, Thielecke H, Puntes VF, Duschl A, Boraschi D.

Part Fibre Toxicol. 2011 Feb 9;8(1):8. doi: 10.1186/1743-8977-8-8.

49.

Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus.

Migliorini P, Anzilotti C, Pratesi F, Quattroni P, Bargagna M, Dinarello CA, Boraschi D.

Eur Cytokine Netw. 2010 Dec;21(4):264-71. doi: 10.1684/ecn.2010.0210. Epub 2010 Dec 3.

50.

IL-1 family nomenclature.

Dinarello C, Arend W, Sims J, Smith D, Blumberg H, O'Neill L, Goldbach-Mansky R, Pizarro T, Hoffman H, Bufler P, Nold M, Ghezzi P, Mantovani A, Garlanda C, Boraschi D, Rubartelli A, Netea M, van der Meer J, Joosten L, Mandrup-Poulsen T, Donath M, Lewis E, Pfeilschifter J, Martin M, Kracht M, Muehl H, Novick D, Lukic M, Conti B, Solinger A, Kelk P, van de Veerdonk F, Gabel C.

Nat Immunol. 2010 Nov;11(11):973. doi: 10.1038/ni1110-973. No abstract available. Erratum in: Nat Immunol. 2011 Mar;12(3):271. Peyman, Kelk [corrected to Kelk, Peyman].

Supplemental Content

Loading ...
Support Center